Mubadala Investment Company, Abu Dhabi’s strategic investment arm, and Novo Holdings, are investing €250 million ($295m) in drug discovery and development firm Evotec.
13
Oct
Oct
Mubadala Investment Company, Abu Dhabi’s strategic investment arm, and Novo Holdings, are investing €250 million ($295m) in drug discovery and development firm Evotec.